Eko Named to the 2021 CB Insights Digital Health 150 List – Most Innovative Digital Health Startups
16 déc. 2021 08h00 HE
|
Eko
OAKLAND, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Eko, a cardiopulmonary digital health company, has been named to the 2021 CB Insights Digital Health 150 list. The third annual ranking honors 150...
Eko and the National Association of Free & Charitable Clinics Partner to Improve Cardiovascular Care in Medically Underserved Communities
30 nov. 2021 08h30 HE
|
Eko
OAKLAND, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Eko, a cardiopulmonary digital health company, today announced its partnership with the National Association of Free & Charitable Clinics...
Healthy Extracts Launches Innovative Brand Influencer Program, Offering Private Label Products and Custom Formulations with High Reward Potential
10 nov. 2021 08h31 HE
|
Healthy Extracts Inc.
LAS VEGAS, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, has launched a unique...
Healthy Extracts Launches High-Potency Organic Citrus Bergamot Formulations with Clinically Proven Heart Benefits, Available Exclusively on Amazon
20 oct. 2021 08h31 HE
|
Healthy Extracts Inc.
LAS VEGAS, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, has launched two new...
Eko’s AI Analysis Algorithm Validated as a Clinical Tool for Detecting Heart Murmurs
10 mai 2021 08h00 HE
|
Eko
OAKLAND, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Eko, a cardiopulmonary digital health company, today announced the peer-reviewed publication of a clinical study that found that the Eko artificial...
Grey Cloak Tech Inc. Announces Strategic Equity Investment from the Medical Community
18 nov. 2020 08h30 HE
|
Grey Cloak Tech Inc.
LAS VEGAS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Grey Cloak Tech Inc. (OTC: GRCK) (soon to be Healthy Extracts Inc. pending a corporate name change), a company engaged in proprietary...
Lexington Biosciences Receives HeartSentry USPTO Patent Approval
25 juil. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, July 25, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Watson Publishes a Guide to Beta-glucan
24 mai 2018 07h32 HE
|
Watson Inc
West Haven, CT -, May 24, 2018 (GLOBE NEWSWIRE) -- Americans consume only about half of the daily recommended amount of dietary fiber. While the new FDA daily value (DV) for fiber is 28 grams, the...
Lexington Announces Brokered Private Placement
04 mai 2018 07h00 HE
|
Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, B.C., May 04, 2018 (GLOBE...
Lexington Begins HeartSentry Clinical Trial
20 févr. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...